Navigation Links
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008
Date:4/9/2008

he conversion rate was dose-dependent.

The Congressional briefing, sponsored by Congressman James Langevin (D-RI), provides an opportunity for members of Congress and their staff to meet with experts, hear a general overview of spinal cord research and to receive an update on the latest advancements and therapeutic interventions. Dr. Hurtt will be joined by Dr. Damien Pearse of the Miami Project, Dr. Stephen Davies, University of Colorado, Dr. Wise Young, Rutgers University and Dr. Simon Archibald, Integra LifeSciences.

Dr. Hurtt commented, "As we continue to develop CETHRIN with the aim of providing a first-ever therapeutic option for nerve repair to patients with acute spinal cord injury, we are committed to the support of the excellent work of the SCI advocacy groups. These groups reach out to patients, care-givers, professional societies and the general public providing valuable educational, quality of life and often research funding opportunities. We are most pleased to have been invited to the 'Working 2 Walk' Conference and to assist their legislative efforts in the U.S. Congress."

About Working 2 Walk

The third annual "Working 2 Walk" Conference to be held April 13-15, 2008 in Washington, DC is a joint project of Unite 2 Fight Paralysis, a nationwide patient advocacy organization, and the Kennedy Krieger Institute of Baltimore, leaders in rehabilitative strategies that restore function after spinal cord injury. The "Working 2 Walk" Science and Educational Symposium provides a setting for researchers, clinicians and the spinal cord injury community to collaborate on strategies necessary to achieve a cure for paralysis.

About Alseres

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Amgen(Nasdaq: AMGN )...rallPipelineandforBestNewDrugforNplate®(romip...erallPipelineawardwaspresentedtoAmgenbyScripinreco...ofthecompany,spipeline,aswellasitsmixofcandidatesa...spipelineisnotableforitsfocusonunmetclinicalneed. ...
(Date:11/23/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...arketforPACSandEMR ,, http://www.reportlinke..._source=prnewswire&utm_medium=pr&utm_campa...svaluedatalmost$1.3billion,representinganincreaseo...500+beds),mediumhospitals(201-499beds),communityho...
(Date:11/23/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...rMonitoringSystems-AGlobalMarketReview ,, ht...ng-Systems---A-Global-Market-Review.html#utm_sourc...newswire ,, Cardiovascularmonitoringisextre...needtobecontinuouslymonitoredduringdiagnosticaswel...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 1eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 2eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 3WAVE Begins Shipment of Vibration Technology to Physiomed Franchises 55358 1WAVE Begins Shipment of Vibration Technology to Physiomed Franchises 55358 2Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 1Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 2Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 3Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 4Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 5
...(Ulleval,University Hospital, Oslo, Norway), lead ...Aortic Stenosis (SEAS) Study, will provide an upda...esent in London will be Sir Richard Peto (Professo...rector of the Clinical Trials Service,Unit, Univer...sor of,Medicine and Epidemiology at the University...
...nal of Nutrition, NEW YORK, July 18 Drinking fou...althy mind and body, according to new research,pub...Journal of Nutrition.,One study,s results suggest ...tention and focus. This and other studies on tea p...lth, genetic susceptibility to cancer, and,insulin...
Other Medicine Technology:New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 2New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 3New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 4New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 5
(Date:11/23/2009)...thylation of arsenic compounds appears to cause ox...nicity, according to a new study published online ... Institute . , Although biomethylation was once ...thought to enhance its toxicity and potentially it...enic biomethylation in oxidative DNA damage in mic...
(Date:11/23/2009)...AND, Ore. Low-income children who don,t access he... long term are significantly more likely to have u...ording to a new study published in the journal Pe...nforming the financing and delivery of quality hea... "In the current policy debates about health insu...
(Date:11/23/2009)...ORK (Nov. 23, 2009) -- A first-of-its-kind consens...ne today in the Annals of Surgery . The report il...consensus conference -- Diabetes Surgery Summit (D...0 scientific and medical experts agreed on a set o...re meant to guide the use and study of gastrointes...
(Date:11/23/2009)...an three-quarters getting chemo deal with insomnia...hDay News) -- Insomnia and sleep disorders affect ...oing chemotherapy, a rate nearly three times highe... finds. , The problem is more common in younger...s, said University of Rochester Medical Center res...
(Date:11/23/2009)...nadine Healy, first woman to head the agency, said... 23 (HealthDay News) -- The fallout from last week...he start of routine mammogram testing for breast c...tional Institutes of Health advising women to igno...y ignore them, because unequivocally this will inc...
Breaking Medicine News(10 mins):Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3
...ruginosa is a potentially life-threatening infecti... infection, doctors often prescribe an inhaled dru... use of this drug is controversial because some pa...concluded that the controversial drug used to trea...
...hows children younger than age 1 can learn certain...1 can learn words // in one context and understand...of 52 children who were 9 months old. The paren...ldren. The games were performed four times a week ...
...udy that looked at how in utero exposures affect t...rs say, larger babies // have a higher risk of dev...ers say associations between larger birth weight a...s on maternal age, gestational age, birth order, b...
...uthorities Health Canada had suspended the use of ...t Hyperactivity Disorder (ADHD) from the market //...rpart of Health Canada has decided to take a wait-...op the medication for their children. Adderall ...
...atest research , sudden emotional stress can resul...hat mimics a classic heart attack.// Stress ca...sive heart attack. According to the researchers, p...toms similar to a typical heart attack including c...
...rally are better than intravenous fluids for child...o a recent study .// Oral rehydration therapy i...ehydration. However, a recent survey reveals that ...directly into a vein. In a study conducted to e...
Other Medicine News:
XT-1800i
SF-3000
Coulter AcT 5diff OV
XE-2100L
Medicine Products: